Endothelial Function in Patients with Obstructive Sleep Apnea Syndrome but Without Hypertension
Overview
Authors
Affiliations
Background: Obstructive sleep apnea syndrome (OSAS) influences endothelial function and causes hypertension.
Objectives: Our aim was to evaluate the role of endothelial dysfunction in the pathogenesis of hypertension in OSAS.
Methods: Twenty-three patients with OSAS but without hypertension and 15 healthy normotensive subjects were investigated. The presence or absence of OSAS was evaluated with a sleep study. Endothelial function was investigated with brachial artery ultrasound examination.
Results: Baseline characteristics were equivalent between the two groups. Minimal oxygen saturation and apnea-hypopnea indexes in the OSAS and control groups were 62.9 +/- 16.5 versus 94.9 +/- 1.1% (p < 0.0001) and 53.1 +/- 20.3 versus 3.8 +/- 0.9 (p < 0.0001), respectively. There was not statistically significant difference between basal brachial artery diameters measured in the morning and in the evening in all groups. Flow-mediated dilation (FMD) values measured in the morning were lower than those measured in the evening in both OSAS patients and the control group: FMD of OSAS patients was 6.04 +/- 3.18% in the morning and 10.38 +/- 4.23% in the evening hours (p = 0.001), and FMD of control subjects was 10.9 +/- 2.6% in the morning and 13.9 +/- 2.32 in the evening hours (p = 0.002). Differences in FMD values measured both in the morning and evening hours in OSAS patients were lower compared with those in control subjects (p < 0.0001 in the morning hours and p = 0.003 in the evening hours).
Conclusions: We detected a prominent diurnal deterioration in endothelial function in normotensive OSAS patients compared with healthy subjects. This deterioration may occur due to ongoing hypoxemia during the night and it may be a possible cause of hypertension and atherosclerotic cardiovascular diseases in patients with OSAS.
Ferreira-Silva R, Goya T, Barbosa E, Durante B, Araujo C, Lorenzi-Filho G J Clin Sleep Med. 2018; 14(9):1463-1470.
PMID: 30176967 PMC: 6134250. DOI: 10.5664/jcsm.7314.
Wang Y, Xu H, Qian Y, Guan J, Yi H, Yin S Med Sci Monit. 2017; 23:1069-1082.
PMID: 28245208 PMC: 5341907. DOI: 10.12659/msm.899716.
Farooqui F, Sharma S, Kumar A, Soneja M, Mani K, Radhakrishnan R Sleep Breath. 2016; 21(1):69-76.
PMID: 27344563 DOI: 10.1007/s11325-016-1371-7.
Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment.
Seetho I, Ramirez-Torres A, Albalat A, Mullen W, Mischak H, Parker R Sleep Sci. 2015; 8(2):58-67.
PMID: 26483946 PMC: 4608901. DOI: 10.1016/j.slsci.2015.06.004.
Dunet V, Rey-Bataillard V, Allenbach G, Beysard N, Lovis A, Prior J Sleep Breath. 2015; 20(2):673-9.
PMID: 26449551 DOI: 10.1007/s11325-015-1272-1.